C Diff Foundation | Strategic Alliance Partners

At 10%, recurrence was lower in this analysis compared to other pediatric studies.

C. difficile infections in travelers returning home could be a cause of travel-associated diarrhea.

Researchers may have stumbled upon a potential new treatment for C. difficile.

Patients with C. difficile are urged to avoid gastric acid suppressants.

Why do some patient care settings have higher rates of C. difficile infection?

Researchers studied the costs associated with various C. difficile treatments.

Some researchers have considered treating C. difficile with fidaxomicin.

Researchers question freeze-dried vs. fresh products in FMT for C. difficile.

Patients’ hospital room floors are frequently contaminated with pathogens.

Age doesn't appear to impact FMT as long as donors are healthy.

Researcher questioned variables that prevent C. diff patients from getting FMT.

Standard antibiotics may not help C. diff infections.

Treating C. difficile infection can be expensive, despite lower incidence rates.

One antibiotic can potentially cut C. diff by 40%.

The main cause of C. difficile is antibiotics, not hospital conditions.

Phase 2 study shows promising results for potential C. difficile vaccine candidate.

C. diff infections appear to lurk in long-term acute care facilities.

C. diff guideline highlights the need for international agreement.

CDC official is hopeful they can beat C diff infection.

Patients using fidaxomicin for C diff infection experienced no recurrences..

Researchers, for the first time, used the lyophilized non-frozen oral capsule RBX7455 to treat a patient with recurrent Clostridium difficile (C. difficile) infection.

While effective for Clostridium difficile (C. difficile) infection in irritable bowel syndrome (IBS) patients, fecal microbiota transplants did not relieve the IBS itself.

Many off label therapeutic options currently exist for treating Clostridium difficile (C. difficile) infection, but combinations of these choices can develop into viable, approved treatments, according to a recently published product review.

Traces of Clostridium difficile bacteria are occasionally found in the final products of manure compost and can even transfer C. difficile into the food chain.

According to new research, fecal transplantations were just as effective as the standard Clostridium difficile (C. difficile) treatment, oral vancomycin taper, in patients with recurrent C. difficile infections.

The antibiotic oral vancomycin can potentially prevent C. difficile infections in patients undergoing stem cell transplants, new research finds.

In a letter, the Textile Rental Services Association strongly responded to the article. David F. Goldsmith, MSPH, PhD, wrote that the story on hospital laundry facilities could “misleadingly create false alarms.”